87 Catalyzed by -ketoacyl-CoA synthase (HMGCS2), two acetyl-CoA molecules combine to form HMG-CoA, which is then broken down into AcAc and acetyl-CoA by HMG-CoA lyase (HMGCL)
Batch-specific COA data should not be used to infer human safety, clinical effectiveness, sterility, endotoxin suitability, or veterinary applicability
Make sure the area is dry before proceeding
Who May Not Be a Good Candidate Peptide therapy may not be appropriate for individuals with: Active or recent history of cancer (GH can promote cell proliferation) Untreated pituitary disorders Uncontrolled diabetes Active proliferative diabetic retinopathy Pregnancy or plans to become pregnant Allergy to peptide components A thorough medical evaluation is necessary to determine suitability
For individuals under high oxidative stress whether from diabetes, aging, or intense training such approaches may offer an additional layer of resilience when guided by professional care